Home·MASTRO BIOLOGICALS PRIVATE LIMITED·Products·Masden
Back to all products

Masden

MASTRO BIOLOGICALS PRIVATE LIMITEDVellore, TN
Storefront
Anchored to the MCA registerCIN U24230TN2021PTC143513
Price on request. Ask the factory for a quote.
MOQ not stated Lead time on requestCurrency INR
Key attributesAll specs
Category
Osteoporosis Care
Place of origin
Vellore, TN, India

About this item

  • Reduces vertebral fractures by up to 68% and hip fractures by 40%.
  • No renal dose adjustments required.

Description

Masden — Denosumab 60 mg/ml RANKL Inhibitor (IgG2). Blocks RANKL–RANK interaction, preventing osteoclast formation. Reduces vertebral fractures by up to 68% and hip fractures by 40% (FREEDOM study). No renal dose adjustments required.

Mechanism

Blocks RANKL–RANK interaction, preventing formation, function, and survival of osteoclasts. Decreases cortical & trabecular bone resorption. Increases BMD at hip, lumbar spine, and femoral neck.

Reviews

Reviews here are order-verified. Only buyers who completed a delivered order can rate this supplier, so the first review appears after the first delivery on BharatSeal.

Questions & answers

Ask the supplier. Answers are visible to all buyers

No questions yet. Ask the first one: the supplier is notified and the answer is posted here for every buyer.

Know your supplier

MASTRO BIOLOGICALS PRIVATE LIMITED
Unverified<1 yr on BharatSealVellore, Tamil Nadu
Year founded
2026

More from Mastro Biologicals